References
- Hvolris MH, Piper TB, Hammer E, et al. Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer. Scand J Gastroenterol. 2016:26:1–6.
- Stefánsson T, Ekbom A, Sparèn P, et al. Increased risk of left sided colon cancer in patients with diverticular disease. Gut. 1993;34:499–502.
- Cooper GS, Xu F, Schluchter MD, et al. Diverticulosis and the risk of interval colorectal cancer. Dig Dis Sci. 2014;59:2765–72.
- Granlund J, Svensson T, Granath F, et al. Diverticular disease and the risk of colon cancer - a population-based case-control study. Aliment Pharmacol Ther. 2011;34:675–81.
- Singh S, Singh PP, Murad MH, et al. Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1375–89.
- Sallinen V, Mentula P, Leppäniemi A. Risk of colon cancer after computed tomography-diagnosed acute diverticulitis: is routine colonoscopy necessary? Surg Endosc. 2014;28:961–6.
- Kieff BJ, Eckert GJ, Imperiale TF. Is diverticulosis associated with colorectal neoplasia? A cross-sectional colonoscopic study. Am J Gastroenterol. 2004;99:2007–11.
- Alexandersson BT, Hreinsson JP, Stefansson T, et al. The risk of colorectal cancer after an attack of uncomplicated diverticulitis. Scand J Gastroenterol. 2014;49:576–80.
- Meurs-Szojda MM, Terhaar sive Droste JS, Kuik DJ, et al. Diverticulosis and diverticulitis form no risk for polyps and colorectal neoplasia in 4,241 colonoscopies. Int J Colorectal Dis. 2008;23:979–84.
- Stefánsson T, Ekbom A, Sparén P, et al. Cancers among patients diagnosed as having diverticular disease of the colon. Eur J Surg. 1995;161:755–60.
- Duffy JM. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem. 2001;47:624–630.
- Holten-Andersen MN, Christensen IJ, Nielsen HJ, et al. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. Clin Cancer Res. 2002;8:156–64.
- Joergensen MT, Brünner N, De Muckadell OB. Comparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer. Anticancer Res. 2010;30:587–92.
- Bernon M, Thomson SR, Jonas E. The rise and fall of CA 19-9. S Afr J Surg. 2013;51:113–4.